199 related articles for article (PubMed ID: 225983)
21. Serum 17 alpha-hydroxyprogesterone in patients with gestational trophoblastic neoplasms.
Osathanondh R; Goldstein DP; Tulchinsky D; Finn AE
Obstet Gynecol; 1977 Jan; 49(1):77-9. PubMed ID: 187990
[TBL] [Abstract][Full Text] [Related]
22. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
Kunhardt J; Calderón J; RodrÃguez S; Fletcher P; Ayala A; Reyes V
Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
[No Abstract] [Full Text] [Related]
23. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
[TBL] [Abstract][Full Text] [Related]
24. [The study for the standard of the remission of the patients with trophoblastic disease (author's transl)].
Katoh T; Endoh N; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):511-20. PubMed ID: 6279745
[TBL] [Abstract][Full Text] [Related]
25. Nature of cross-reaction between hCG and anti-oLH serum and development of a radioimmunoassay to measure hLH specifically in the presence of hCG.
Dattatreyamurty B; Sheth AR; Purandare TV; Rao SS
Endocrinology; 1976 Dec; 99(6):1554-61. PubMed ID: 63368
[TBL] [Abstract][Full Text] [Related]
26. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
28. Clinical use of HCG and hCG beta determinations.
Mann K; Saller B; Hoermann R
Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
[TBL] [Abstract][Full Text] [Related]
29. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
30. The utility of a rapid assay for human chorionic gonadotropin in the management of trophoblastic disease.
Soules MR; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1979 Oct; 135(3):384-92. PubMed ID: 225953
[TBL] [Abstract][Full Text] [Related]
31. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
[TBL] [Abstract][Full Text] [Related]
32. Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine.
Ayala AR; Nisula BC; Chen HC; Hodgen GD; Ross GT
J Clin Endocrinol Metab; 1978 Oct; 47(4):767-73. PubMed ID: 95624
[TBL] [Abstract][Full Text] [Related]
33. The use of a radioimmunoassay specific for human chorionic gonadotropin in patients with molar pregnancy and gestational trophoblastic disease.
Pastorfide GB; Goldstein DP; Kosasa TS
Am J Obstet Gynecol; 1974 Dec; 120(8):1025-8. PubMed ID: 4372889
[No Abstract] [Full Text] [Related]
34. Identification of a heterodimer-specific epitope present in human chorionic gonadotrophin (hCG) using a monoclonal antibody that can distinguish between hCG and human LH.
Gadkari RA; Roy S; Rekha N; Srinivasan N; Dighe RR
J Mol Endocrinol; 2005 Jun; 34(3):879-87. PubMed ID: 15956355
[TBL] [Abstract][Full Text] [Related]
35. Management and outcome of healthy women with a persistently elevated beta-hCG.
Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
[TBL] [Abstract][Full Text] [Related]
36. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin.
Jones WB; Lewis JL; Lehr M
Am J Obstet Gynecol; 1975 Mar; 121(5):669-73. PubMed ID: 46716
[TBL] [Abstract][Full Text] [Related]
37. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
38. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
Quigley MM; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
[TBL] [Abstract][Full Text] [Related]
39. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
